Provided by Tiger Trade Technology Pte. Ltd.

Simplify High Yield ETF

20.25
+0.07500.37%
Post-market: 20.250.00000.00%19:30 EDT
Volume:99.85K
Turnover:2.02M
Market Cap:320.88M
PE:- -
High:20.32
Open:20.17
Low:20.17
Close:20.17
52wk High:22.95
52wk Low:20.06
Shares:15.85M
Float Shares:15.85M
Volume Ratio:0.51
T/O Rate:0.63%
Dividend:1.68
Dividend Rate:8.30%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

US High-Yield Bond Supply Flood Hits Investor Demand as Goldman Sachs Warns Risk Premiums Reach Five-Month High

Stock News
·
Sep 29

SoftBank Gains Massive Investor Backing for OpenAI Bet as Junk Bond Sale Draws Over $20 Billion in Preliminary Orders

Stock News
·
Sep 22

SoftBank's Monumental Junk Bond Raise Attracts Over $20 Billion in Early Demand

Deep News
·
Sep 22

Meta-Backed Data Center Debuts in Junk Bond Market With Overwhelming Demand

Stock News
·
Sep 19

Arena REIT posts higher FY2026 profits and navigates tenant default risk

TIPRANKS
·
Aug 21

Steep Price Tag for AI Infrastructure Funding: BlackRock's QTS Sells Investment-Grade Bonds at High-Yield Rates with Sixfold Demand

Deep News
·
Aug 19

Standard Chartered revamps leveraged finance team to focus on sponsors

Megawati Wijaya / Bloomberg
·
Aug 19

Global Corn Group shifts from debt restructuring to winding up key subsidiary to tackle audit disclaimer

TIPRANKS
·
Aug 07

Nostrum Oil & Gas launches tender offer amid revised debt restructuring and Kazakh tax disputes

TIPRANKS
·
Jul 24

SpaceX Bond Yields Surge into High-Yield Territory

Deep News
·
Jul 15

Celldex presents first-in-human results for CDX-622

TIPRANKS
·
Jun 15

Press Release: BioLineRx Reports First Quarter 2026 Financial Results and Provides Corporate Update

Dow Jones
·
May 27

BioLineRx Drug Shows Anti-Tumor Activity In Brain Tumor Animal Models

Benzinga
·
May 20

Junshi Biosciences Presents Results from JS207 (PD-1/VEGF BsAb) Phase 2 Combo Studies and JS212 (EGFR/HER3 ADC) FIH Phase 1/2 Study at AACR 2026

GlobeNewswire
·
Apr 21